Showing results (41-50 of 98) with videos related to
Sort By:
Pageof 10
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 15, 2022
Four-factor prothrombin complex concentrate plus andexanet alfa for reversal of factor Xa inhibitor-associated bleeding: Case seriesJiTong Liu, Pansy Elsamadisi, Eli Philips, et al.Chest|August 11, 2004
Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end pointsAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.Journal of the Southern Orthopaedic Association|February 25, 2003
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgeryAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.Journal of the Southern Orthopaedic Association|February 25, 2003
A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialistKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.Archives of Internal Medicine|August 28, 2002
Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studiesAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.Chest|December 12, 2003
New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studiesAlexander G G Turpie, Bengt I Eriksson, Kenneth A Bauer, et al.Current Opinion in Pulmonary Medicine|August 13, 2002
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolismKenneth A Bauer, Bengt I Eriksson, Michael R Lassen, et al.Lancet (London, England)|June 7, 2002
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparisonMichael Rud Lassen, Kenneth A Bauer, Bengt I Eriksson, et al.Lancet (London, England)|June 7, 2002
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trialAlexander G G Turpie, Kenneth A Bauer, Bengt I Eriksson, et al.Current Opinion in Hematology|August 13, 2003
Fondaparinux, the first selective factor Xa inhibitorAlexander G G Turpie, Bengt I Eriksson, Michael R Lassen, et al.Pageof 10